Related Experiment Videos
Renal micropolyarteritis: a treatable condition
Abstract:
A 10-year retrospective study of 36 patients is presented; the patients comprised 27 with renal micropolyarteritis nodosa (microPAN) and nine with Wegener's granulomatosis. At presentation, 29 patients had significant renal impairment (creatinine greater than 150 mumol/l), with 18 requiring dialysis at some time during their illness. Eighteen patients showed rapid recovery of renal function, a further two with apparently chronic renal failure recovered renal function after 4 months dialysis and continued immunosuppression. Seven patients required chronic dialysis. No benefit was shown for any particular immunosuppressive regime, with three patients recovering renal function (two initially on dialysis) without any immunosuppression. Prognosis was better than in previous published series, especially considering the elderly population (mean 52.9 years), with an 80% 1-year and a 64% 5-year survival.
Insights
This study on renal vasculitis found that prognosis is better than previously reported, with significant renal recovery possible even in elderly patients. Immunosuppression did not show a clear benefit for kidney function recovery.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Vasculitis affecting the kidneys, such as microscopic polyarteritis nodosa (microPAN) and Wegener's granulomatosis, can lead to severe renal impairment.
- Previous studies have indicated a poor prognosis for patients with renal vasculitis.
Purpose of the Study:
- To evaluate the long-term outcomes and prognostic factors in patients with renal vasculitis.
- To assess the effectiveness of different immunosuppressive regimens on renal recovery.
Main Methods:
- A 10-year retrospective study involving 36 patients with renal microPAN or Wegener's granulomatosis.
- Analysis of renal function, need for dialysis, treatment regimens, and survival rates.
Main Results:
- 29 out of 36 patients presented with significant renal impairment, and 18 required dialysis.
- 18 patients experienced rapid renal function recovery; two more recovered after dialysis.
- No specific immunosuppressive regimen demonstrated a clear benefit; some patients recovered without immunosuppression.
- Overall survival was 80% at 1 year and 64% at 5 years, which is better than previously reported, especially for an elderly cohort.
Conclusions:
- Renal vasculitis, including microPAN and Wegener's granulomatosis, has a better prognosis than previously thought, with potential for significant renal recovery.
- The role and benefit of specific immunosuppressive therapies require further investigation, as recovery can occur even without immunosuppression.